Drug Type Small molecule drug |
Synonyms L-sulpiride, Levobren, Levosulpiride (INN) + [5] |
Target |
Mechanism DRDs antagonists(Dopamine receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date IT (13 Aug 2003), |
Regulation- |
Molecular FormulaC15H23N3O4S |
InChIKeyBGRJTUBHPOOWDU-NSHDSACASA-N |
CAS Registry23672-07-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07312 | Levosulpiride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dyspepsia | KR | 11 Apr 2024 | |
Depressive Disorder, Major | IT | - | 17 Aug 2003 |
Nausea and vomiting | IT | - | 13 Aug 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute vomiting | Phase 2 | CN | 10 Mar 2014 | |
Acute vomiting | Phase 2 | CN | 10 Mar 2014 | |
Acute vomiting | Phase 2 | CN | 10 Mar 2014 |
Phase 1 | - | 42 | wasnergndx(hhvjdspmtb) = tpwbveofpo bxbczcnfcg (ccbcvdjhbh ) View more | - | 01 Nov 2015 | ||
wasnergndx(hhvjdspmtb) = qbxcakhvzu bxbczcnfcg (ccbcvdjhbh ) View more |